Predicting the gastrointestinal behaviour of modified-release products: Utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers-Reference-Cited by-同舟云学术

Predicting the gastrointestinal behaviour of modified-release products: Utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers

Published:2014-11 Issue:1-2 Volume:475 Page:585-591
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Merchant Hamid A.,Goyanes Alvaro,Parashar Narendra,Basit Abdul W.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference34 articles.

1. Acute undifferentiated human diarrhoea in the tropics;Banwell;J. Clin. Invest.,1971

2. Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs;Bergstrom;Eur. J. Pharm. Sci.,2014

3. Is bicarbonate buffer suitable as a dissolution medium?;Boni;J. Pharm. Pharmacol.,2007

4. Prolonged recording of duodenal acid exposure in patients with functional dyspepsia and controls using a radiotelemetry pH monitoring system;Bratten;J. Clin. Gastroenterol.,2009

5. Comparison of the release profiles of a water soluble drug carried by Eudragit-coated capsules in different in-vitro dissolution liquids;Chan;Powder Tech.,2001

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Crystal Precipitation in Biorelevant Bicarbonate Buffer: A Well-Controlled Comparative Study with Phosphate Buffer;Molecular Pharmaceutics;2024-05-08

2. Dissolution Profiles of Oral Disintegrating Tablet with Taste Masking Granule Polymer Coating in Biorelevant Bicarbonate Buffer;Chemical and Pharmaceutical Bulletin;2024-03-13

3. Colon-responsive oral drug delivery for combating colonic disorders;Advanced Drug Delivery Systems for Colonic Disorders;2024

4. Development of bicarbonate buffer flow-through cell dissolution test and its application in prediction of in vivo performance of colon targeting tablets;European Journal of Pharmaceutical Sciences;2023-01

5. Targeted colonic release formulations of mesalazine – A clinical pharmaco-scintigraphic proof-of-concept study in healthy subjects and patients with mildly active ulcerative colitis;International Journal of Pharmaceutics;2022-09